Literature DB >> 31525070

Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction.

Sara Leite1, Rui J Cerqueira1,2, Jaime Ibarrola3, Dulce Fontoura1, Amaya Fernández-Celis3, Faiez Zannad4, Inês Falcão-Pires1, Walter J Paulus5, Adelino F Leite-Moreira1,2, Patrick Rossignol4, Natalia López-Andrés3,4, André P Lourenço1,6.   

Abstract

BACKGROUND: The interplay between the stiffened heart and vessels has long been viewed as a core mechanism in heart failure with preserved ejection fraction, but the incremental vascular molecular remodeling mechanisms from systemic arterial hypertension to heart failure with preserved ejection fraction remain poorly investigated. Our aim was to characterize central arterial remodeling and dysfunction in ZSF1 obese rats and to compare it with hypertensive ZSF1 lean and healthy Wistar-Kyoto controls. METHODS AND
RESULTS: Twenty-week-old male ZSF1 obese (n=9), lean (n=9), and Wistar-Kyoto rats (n=9) underwent left ventricular pressure-volume loop evaluation and synchronous acquisition of ascending aortic flow and pressure. Aortic rings underwent functional evaluation, histology, and molecular biology studies. Although mean arterial pressure, characteristic aortic impedance, and reactivity to phenylephrine were similarly increased in hypertensive ZSF1 lean and obese, only ZSF1 obese showed impaired relaxation and upward-shifted end-diastolic pressure-volume relationships despite preserved systolic function indexes, denoting heart failure with preserved ejection fraction. ZSF1 obese phenotype further showed decreased aortic compliance, increased wave reflection, and impaired direct NO donor and endothelial-mediated vasodilation which were accompanied on structural and molecular grounds by aortic media thickening, higher collagen content and collagen/elastin ratio, increased fibronectin and α-5 integrin protein expression and upregulated TGF (transforming growth factor)-β and CTGF (connective tissue growth factor) levels.
CONCLUSIONS: Functional, molecular, and structural disturbances of central vessels and their potentially underlying pathways were newly characterized in experimental heart failure with preserved ejection fraction rendering the ZSF1 obese rat model suitable for preclinical testing.

Entities:  

Keywords:  biology; extracellular matrix; heart failure; hypertension; vascular remodeling

Mesh:

Year:  2019        PMID: 31525070     DOI: 10.1161/CIRCHEARTFAILURE.118.005596

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  8 in total

Review 1.  Mimicking Metabolic Disturbance in Establishing Animal Models of Heart Failure With Preserved Ejection Fraction.

Authors:  Hui Li; Yi-Yuan Xia; Chun-Lei Xia; Zheng Li; Yi Shi; Xiao-Bo Li; Jun-Xia Zhang
Journal:  Front Physiol       Date:  2022-05-03       Impact factor: 4.755

Review 2.  Cellular and molecular pathobiology of heart failure with preserved ejection fraction.

Authors:  Sumita Mishra; David A Kass
Journal:  Nat Rev Cardiol       Date:  2021-01-11       Impact factor: 49.421

3.  ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction.

Authors:  Antje Schauer; Runa Draskowski; Anett Jannasch; Virginia Kirchhoff; Keita Goto; Anita Männel; Peggy Barthel; Antje Augstein; Ephraim Winzer; Malte Tugtekin; Siegfried Labeit; Axel Linke; Volker Adams
Journal:  ESC Heart Fail       Date:  2020-07-25

Review 4.  Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction: What are the Experimental Proofs?

Authors:  Lauriane Cornuault; Paul Rouault; Cécile Duplàa; Thierry Couffinhal; Marie-Ange Renault
Journal:  Front Physiol       Date:  2022-07-08       Impact factor: 4.755

5.  The effect of different anaesthetics on echocardiographic evaluation of diastolic dysfunction in a heart failure with preserved ejection fraction model.

Authors:  Ilona Cuijpers; Paolo Carai; Pedro Mendes-Ferreira; Steven J Simmonds; Paul Mulder; Daniela Miranda-Silva; Daria De Giorgio; Peter Pokreisz; Stephane Heymans; Elizabeth A V Jones
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

Review 6.  Oxidative Stress and Vascular Damage in the Context of Obesity: The Hidden Guest.

Authors:  Ernesto Martínez-Martínez; Francisco V Souza-Neto; Sara Jiménez-González; Victoria Cachofeiro
Journal:  Antioxidants (Basel)       Date:  2021-03-08

7.  Sacubitril/Valsartan Improves Diastolic Function But Not Skeletal Muscle Function in a Rat Model of HFpEF.

Authors:  Antje Schauer; Volker Adams; Antje Augstein; Anett Jannasch; Runa Draskowski; Virginia Kirchhoff; Keita Goto; Jeniffer Mittag; Roberta Galli; Anita Männel; Peggy Barthel; Axel Linke; Ephraim B Winzer
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

Review 8.  Distinctive patterns of inflammation across the heart failure syndrome.

Authors:  Gabriele G Schiattarella; Vasco Sequeira; Pietro Ameri
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.